Structural and functional remodeling of the left atrium: Clinical and therapeutic implications for atrial fibrillation

Journal of Atrial Fibrillation

Volumn 6, Issue 4, 2013, Pages 53-64

  Pathak, Rajeev ^a   Lau, Dennis H ^a   Mahajan, Rajiv ^a   Sanders, Prashanthan ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIHYPERTENSIVE AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; OMEGA 3 FATTY ACID; PIRFENIDONE;

AGING; ANTIHYPERTENSIVE THERAPY; CLINICAL PRACTICE; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; HEART ATRIUM FIBRILLATION; HEART ATRIUM SEPTUM DEFECT; HUMAN; HYPERTENSION; INFLAMMATION; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; SLEEP DISORDERED BREATHING; VALVULAR HEART DISEASE; WEIGHT REDUCTION;

EID: 84892888433     PISSN: None     EISSN: 19416911     Source Type: Journal    
DOI: None     Document Type: Review

References (185)

1. Benjamin EJ, Chen PS, Bild DE, Mascette AM, Albert CM, Alonso A, Calkins H, Connolly SJ, Curtis AB, Darbar D, Ellinor PT, Go AS, Goldschlager NF, Heckbert SR, Jalife J, Kerr CR, Levy D, Lloyd-Jones DM, Massie BM, Nattel S, Olgin JE, Packer DL, Po SS, Tsang TS, Van Wagoner DR, Waldo AL, Wyse DG. Prevention of atrial fibrillation: Report from a national heart, lung, and blood institute workshop. Circulation 2009;119:606-618.
2. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The anticoagulation and risk factors in atrial fibrillation (atria) study. JAMA 2001;285:2370-2375.
3. Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, Seward JB, Tsang TS. Secular trends in incidence of atrial fibrillation in olmsted county, minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006;114:119-125.
4. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: The framingham heart study. Circulation 1998;98:946-952.
5. Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna W, Seward JB, Iwasaka T, Tsang TS. Incidence and mortality risk of congestive heart failure in atrial fibrillation patients: A community-based study over two decades. European heart journal 2006;27:936-941.
6. Dorian P, Jung W, Newman D, Paquette M, Wood K, Ayers GM, Camm J, Akhtar M, Luderitz B. The impairment of health-related quality of life in patients with intermittent atrial fibrillation: Implications for the assessment of investigational therapy. J Am Coll Cardiol 2000;36:1303-1309.
7. Miyasaka Y, Barnes ME, Petersen RC, Cha SS, Bailey KR, Gersh BJ, Casaclang-Verzosa G, Abhayaratna WP, Seward JB, Iwasaka T, Tsang TS. Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: Data from a community-based cohort. European heart journal 2007;28:1962-1967.
8. Wong CX, Brooks AG, Leong DP, Roberts-Thomson KC, Sanders P. The increasing burden of atrial fibrillation compared with heart failure and myocardial infarction: A 15-year study of all hospitalizations in australia. Arch Intern Med 2012;172:739-741.
9. Wong CX, Brooks AG, Lau DH, Leong DP, Sun MT, Sullivan T, Roberts-Thomson KC, Sanders P. Factors associated with the epidemic of hospitalizations due to atrial fibrillation. The American journal of cardiology 2012;110:1496-1499.
10. Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, Said SA, Darmanata JI, Timmermans AJ, Tijssen JG, Crijns HJ. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. The New England journal of medicine 2002;347:1834-1840.
11. Brooks AG, Stiles MK, Laborderie J, Lau DH, Kuklik P, Shipp NJ, Hsu LF, Sanders P. Outcomes of long-standing persistent atrial fibrillation ablation: A systematic review. Heart Rhythm 2010;7:835-846.
12. Nattel S, Burstein B, Dobrev D. Atrial remodeling and atrial fibrillation: Mechanisms and implications. Circulation Arrhythmia and electrophysiology 2008;1:62-73.
13. Schotten U, Verheule S, Kirchhof P, Goette A. Pathophysiological mechanisms of atrial fibrillation: A translational appraisal. Physiol Rev 2011;91:265-325.
14. Allessie MA, Boyden PA, Camm AJ, Kleber AG, Lab MJ, Legato MJ, Rosen MR, Schwartz PJ, Spooner PM, Van Wagoner DR, Waldo AL. Pathophysiology and prevention of atrial fibrillation. Circulation 2001;103:769-777.
15. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995;92:1954-1968.
16. Wijffels MC, Kirchhof CJ, Dorland R, Power J, Allessie MA. Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats: Roles of neurohumoral changes, ischemia, atrial stretch, and high rate of electrical activation. Circulation 1997;96:3710-3720.
17. Sun H, Chartier D, Leblanc N, Nattel S. Intracellular calcium changes and tachycardia-induced contractile dysfunction in canine atrial myocytes. Cardiovascular research 2001;49:751-761.
18. Gaspo R, Bosch RF, Bou-Abboud E, Nattel S. Tachycardia-induced changes in na+ current in a chronic dog model of atrial fibrillation. Circ Res 1997;81:1045-1052.
19. Neef S, Dybkova N, Sossalla S, Ort KR, Fluschnik N, Neumann K, Seipelt R, Schondube FA, Hasenfuss G, Maier LS. Camkii-dependent diastolic sr ca2+ leak and elevated diastolic ca2+ levels in right atrial myocardium of patients with atrial fibrillation. Circulation research 2010;106:1134-1144.
20. Hove-Madsen L, Llach A, Bayes-Genis A, Roura S, Rodriguez Font E, Aris A, Cinca J. Atrial fibrillation is associated with increased spontaneous calcium release from the sarcoplasmic reticulum in human atrial myocytes. Circulation 2004;110:1358-1363.
21. Vest JA, Wehrens XH, Reiken SR, Lehnart SE, Dobrev D, Chandra P, Danilo P, Ravens U, Rosen MR, Marks AR. Defective cardiac ryanodine receptor regulation during atrial fibrillation. Circulation 2005;111:2025-2032.
22. Grimm RA, Stewart WJ, Arheart K, Thomas JD, Klein AL. Left atrial appendage "stunning" after electrical cardioversion of atrial flutter: An attenuated response compared with atrial fibrillation as the mechanism for lower susceptibility to thromboembolic events. Journal of the American College of Cardiology 1997;29:582-589.
23. Grimm RA, Stewart WJ, Maloney JD, Cohen GI, Pearce GL, Salcedo EE, Klein AL. Impact of electrical cardioversion for atrial fibrillation on left atrial appendage function and spontaneous echo contrast: Characterization by simultaneous transesophageal echocardiography. Journal of the American College of Cardiology 1993;22:1359-1366.
24. Manning WJ, Silverman DI, Katz SE, Riley MF, Come PC, Doherty RM, Munson JT, Douglas PS. Impaired left atrial mechanical function after cardioversion: Relation to the duration of atrial fibrillation. Journal of the American College of Cardiology 1994;23:1535-1540.
25. Yue L, Feng J, Gaspo R, Li GR, Wang Z, Nattel S. Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. Circulation research 1997;81:512-525.
26. Schotten U, Ausma J, Stellbrink C, Sabatschus I, Vogel M, Frechen D, Schoendube F, Hanrath P, Allessie MA. Cellular mechanisms of depressed atrial contractility in patients with chronic atrial fibrillation. Circulation 2001;103:691-698.
27. Sanders P, Morton JB, Kistler PM, Vohra JK, Kalman JM, Sparks PB. Reversal of atrial mechanical dysfunction after cardioversion of atrial fibrillation: Implications for the mechanisms of tachycardia-mediated atrial cardiomyopathy. Circulation 2003;108:1976-1984.
28. Sanders P, Morton JB, Morgan JG, Davidson NC, Spence SJ, Vohra JK, Kalman JM, Sparks PB. Reversal of atrial mechanical stunning after cardioversion of atrial arrhythmias: Implications for the mechanisms of tachycardia-mediated atrial cardiomyopathy. Circulation 2002;106:1806-1813.
29. Schotten U, Greiser M, Benke D, Buerkel K, Ehrenteidt B, Stellbrink C, Vazquez-Jimenez JF, Schoendube F, Hanrath P, Allessie M. Atrial fibrillation-induced atrial contractile dysfunction: A tachycardiomyopathy of a different sort. Cardiovascular research 2002;53:192-201.
30. Manning WJ, Silverman DI, Katz SE, Riley MF, Doherty RM, Munson JT, Douglas PS. Temporal dependence of the return of atrial mechanical function on the mode of cardioversion of atrial fibrillation to sinus rhythm. Am J Cardiol 1995;75:624-626.
31. Allessie M, Ausma J, Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res 2002;54:230-246.
32. Li D, Fareh S, Leung TK, Nattel S. Promotion of atrial fibrillation by heart failure in dogs: Atrial remodeling of a different sort. Circulation 1999;100:87-95.
33. Casaclang-Verzosa G, Gersh BJ, Tsang TS. Structural and functional remodeling of the left atrium: Clinical and therapeutic implications for atrial fibrillation. Journal of the American College of Cardiology 2008;51:1-11.
34. Ausma J, Wijffels M, Thone F, Wouters L, Allessie M, Borgers M. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation 1997;96:3157-3163.
35. Rucker-Martin C, Pecker F, Godreau D, Hatem SN. Dedifferentiation of atrial myocytes during atrial fibrillation: Role of fibroblast proliferation in vitro. Cardiovascular research 2002;55:38-52.
36. Aime-Sempe C, Folliguet T, Rucker-Martin C, Krajewska M, Krajewska S, Heimburger M, Aubier M, Mercadier JJ, Reed JC, Hatem SN. Myocardial cell death in fibrillating and dilated human right atria. Journal of the American College of Cardiology 1999;34:1577-1586.
37. Xu J, Cui G, Esmailian F, Plunkett M, Marelli D, Ardehali A, Odim J, Laks H, Sen L. Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation. Circulation 2004;109:363-368.
38. Verheule S, Tuyls E, van Hunnik A, Kuiper M, Schotten U, Allessie M. Fibrillatory conduction in the atrial free walls of goats in persistent and permanent atrial fibrillation. Circ Arrhythm Electrophysiol 2010;3:590-599.
39. Verheule S, Tuyls E, Gharaviri A, Hulsmans S, van Hunnik A, Kuiper M, Serroyen J, Zeemering S, Kuijpers NH, Schotten U. Loss of continuity in the thin epicardial layer because of endomysial fibrosis increases the complexity of atrial fibrillatory conduction. Circ Arrhythm Electrophysiol 2013;6:202-211.
40. Wyse DG, Gersh BJ. Atrial fibrillation: A perspective: Thinking inside and outside the box. Circulation 2004;109:3089-3095.
41. Vaziri SM, Larson MG, Lauer MS, Benjamin EJ, Levy D. Influence of blood pressure on left atrial size. The framingham heart study. Hypertension 1995;25:1155-1160.
42. Satoh T, Zipes DP. Unequal atrial stretch in dogs increases dispersion of refractoriness conducive to developing atrial fibrillation. Journal of cardiovascular electrophysiology 1996;7:833-842.
43. Ravelli F, Mase M, del Greco M, Marini M, Disertori M. Acute atrial dilatation slows conduction and increases af vulnerability in the human atrium. Journal of cardiovascular electrophysiology 2011;22:394-401.
44. Elvan A, Adiyaman A, Beukema RJ, Sie HT, Allessie MA. Electrophysiological effects of acute atrial stretch on persistent atrial fibrillation in patients undergoing open heart surgery. Heart Rhythm 2013;10:322-330.
45. Wong CX, John B, Brooks AG, Chandy ST, Kuklik P, Lau DH, Sullivan T, Roberts-Thomson KC, Sanders P. Direction-dependent conduction abnormalities in the chronically stretched atria. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2012;14:954-961.
46. Roberts-Thomson KC, Stevenson I, Kistler PM, Haqqani HM, Spence SJ, Goldblatt JC, Sanders P, Kalman JM. The role of chronic atrial stretch and atrial fibrillation on posterior left atrial wall conduction. Heart Rhythm 2009;6:1109-1117.
47. Li GR, Feng J, Wang Z, Nattel S. Transmembrane chloride currents in human atrial myocytes. Am J Physiol 1996;270:C500-507.
48. Ravelli F, Allessie M. Effects of atrial dilatation on refractory period and vulnerability to atrial fibrillation in the isolated langendorff-perfused rabbit heart. Circulation 1997;96:1686-1695.
49. Ninio DM, Saint DA. The role of stretch-activated channels in atrial fibrillation and the impact of intracellular acidosis. Progress in biophysics and molecular biology 2008;97:401-416.
50. Brand FN, Abbott RD, Kannel WB, Wolf PA. Characteristics and prognosis of lone atrial fibrillation. 30-year follow-up in the framingham study. JAMA 1985;254:3449-3453.
51. Schnabel RB, Sullivan LM, Levy D, Pencina MJ, Massaro JM, D'Agostino RB, Sr., Newton-Cheh C, Yamamoto JF, Magnani JW, Tadros TM, Kannel WB, Wang TJ, Ellinor PT, Wolf PA, Vasan RS, Benjamin EJ. Development of a risk score for atrial fibrillation (framingham heart study): A community-based cohort study. Lancet 2009;373:739-745.
52. Spach MS, Heidlage JF, Dolber PC, Barr RC. Mechanism of origin of conduction disturbances in aging human atrial bundles: Experimental and model study. Heart rhythm : the official journal of the Heart Rhythm Society 2007;4:175-185.
53. Hayashi H, Wang C, Miyauchi Y, Omichi C, Pak HN, Zhou S, Ohara T, Mandel WJ, Lin SF, Fishbein MC, Chen PS, Karagueuzian HS. Aging-related increase to inducible atrial fibrillation in the rat model. J Cardiovasc Electrophysiol 2002;13:801-808.
54. Anyukhovsky EP, Sosunov EA, Plotnikov A, Gainullin RZ, Jhang JS, Marboe CC, Rosen MR. Cellular electrophysiologic properties of old canine atria provide a substrate for arrhythmogenesis. Cardiovasc Res 2002;54:462-469.
55. Kistler PM, Sanders P, Fynn SP, Stevenson IH, Spence SJ, Vohra JK, Sparks PB, Kalman JM. Electrophysiologic and electroanatomic changes in the human atrium associated with age. Journal of the American College of Cardiology 2004;44:109-116.
56. Roberts-Thomson KC, Kistler PM, Sanders P, Morton JB, Haqqani HM, Stevenson I, Vohra JK, Sparks PB, Kalman JM. Fractionated atrial electrograms during sinus rhythm: Relationship to age, voltage, and conduction velocity. Heart Rhythm 2009;6:587-591.
57. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The framingham heart study. JAMA : the journal of the American Medical Association 1994;271:840-844.
58. Maisel WH, Stevenson LW. Atrial fibrillation in heart failure: Epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol 2003;91:2D-8D.
59. Lau DH, Psaltis PJ, Mackenzie L, Kelly DJ, Carbone A, Worthington M, Nelson AJ, Zhang Y, Kuklik P, Wong CX, Edwards J, Saint DA, Worthley SG, Sanders P. Atrial remodeling in an ovine model of anthracycline-induced nonischemic cardiomyopathy: Remodeling of the same sort. J Cardiovasc Electrophysiol 2011;22:175-182.
60. Sridhar A, Nishijima Y, Terentyev D, Khan M, Terentyeva R, Hamlin RL, Nakayama T, Gyorke S, Cardounel AJ, Carnes CA. Chronic heart failure and the substrate for atrial fibrillation. Cardiovasc Res 2009;84:227-236.
61. Sanders P, Morton JB, Davidson NC, Spence SJ, Vohra JK, Sparks PB, Kalman JM. Electrical remodeling of the atria in congestive heart failure: Electrophysiological and electroanatomic mapping in humans. Circulation 2003;108:1461-1468.
62. Psaty BM, Manolio TA, Kuller LH, Kronmal RA, Cushman M, Fried LP, White R, Furberg CD, Rautaharju PM. Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997;96:2455-2461.
63. Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: Population-based estimates. Am J Cardiol 1998;82:2N-9N.
64. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: Incidence, risk factors, and prognosis in the manitoba follow-up study. Am J Med 1995;98:476-484.
65. Loaldi A, Pepi M, Agostoni PG, Fiorentini C, Grazi S, Della Bella P, Guazzi MD. Cardiac rhythm in hypertension assessed through 24 hour ambulatory electrocardiographic monitoring. Effects of load manipulation with atenolol, verapamil, and nifedipine. British heart journal 1983;50:118-126.
66. Gerdts E, Oikarinen L, Palmieri V, Otterstad JE, Wachtell K, Boman K, Dahlof B, Devereux RB, Losartan Intervention For Endpoint Reduction in Hypertension S. Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy: The losartan intervention for endpoint reduction in hypertension (life) study. Hypertension 2002;39:739-743.
67. Lau DH, Mackenzie L, Kelly DJ, Psaltis PJ, Worthington M, Rajendram A, Kelly DR, Nelson AJ, Zhang Y, Kuklik P, Brooks AG, Worthley SG, Faull RJ, Rao M, Edwards J, Saint DA, Sanders P. Short-term hypertension is associated with the development of atrial fibrillation substrate: A study in an ovine hypertensive model. Heart Rhythm 2010;7:396-404.
68. Kistler PM, Sanders P, Dodic M, Spence SJ, Samuel CS, Zhao C, Charles JA, Edwards GA, Kalman JM. Atrial electrical and structural abnormalities in an ovine model of chronic blood pressure elevation after prenatal corticosteroid exposure: Implications for development of atrial fibrillation. Eur Heart J 2006;27:3045-3056.
69. Lau DH, Mackenzie L, Kelly DJ, Psaltis PJ, Brooks AG, Worthington M, Rajendram A, Kelly DR, Zhang Y, Kuklik P, Nelson AJ, Wong CX, Worthley SG, Rao M, Faull RJ, Edwards J, Saint DA, Sanders P. Hypertension and atrial fibrillation: Evidence of progressive atrial remodeling with electrostructural correlate in a conscious chronically instrumented ovine model. Heart Rhythm 2010;7:1282-1290.
70. Lau DH, Middeldorp ME, Brooks AG, Ganesan AN, Roberts-Thomson KC, Stiles MK, Leong DP, Abed HS, Lim HS, Wong CX, Willoughby SR, Young GD, KALMAN JM, Abhayaratna WP, Sanders P. Aortic stiffness in lone atrial fibrillation: A novel risk factor for arrhythmia recurrence. PLoS One 2013;8:e76776.
71. Barbier P, Alioto G, Guazzi MD. Left atrial function and ventricular filling in hypertensive patients with paroxysmal atrial fibrillation. Journal of the American College of Cardiology 1994;24:165-170.
72. Huxley RR, Filion KB, Konety S, Alonso A. Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation. The American journal of cardiology 2011;108:56-62.
73. Kato T, Yamashita T, Sekiguchi A, Sagara K, Takamura M, Takata S, Kaneko S, Aizawa T, Fu LT. What are arrhythmogenic substrates in diabetic rat atria? Journal of cardiovascular electrophysiology 2006;17:890-894.
74. Mitasikova M, Lin H, Soukup T, Imanaga I, Tribulova N. Diabetes and thyroid hormones affect connexin-43 and pkc-epsilon expression in rat heart atria. Physiological research / Academia Scientiarum Bohemoslovaca 2009;58:211-217.
75. Kato T, Yamashita T, Sekiguchi A, Tsuneda T, Sagara K, Takamura M, Kaneko S, Aizawa T, Fu LT. Ages-rage system mediates atrial structural remodeling in the diabetic rat. J Cardiovasc Electrophysiol 2008;19:415-420.
76. Anderson EJ, Kypson AP, Rodriguez E, Anderson CA, Lehr EJ, Neufer PD. Substrate-specific derangements in mitochondrial metabolism and redox balance in the atrium of the type 2 diabetic human heart. Journal of the American College of Cardiology 2009;54:1891-1898.
77. Wanahita N, Messerli FH, Bangalore S, Gami AS, Somers VK, Steinberg JS. Atrial fibrillation and obesity - results of a meta-analysis. American heart journal 2008;155:310-315.
78. Tsang TS, Barnes ME, Miyasaka Y, Cha SS, Bailey KR, Verzosa GC, Seward JB, Gersh BJ. Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: A longitudinal cohort study of 21 years. European heart journal 2008;29:2227-2233.
79. Wang TJ, Parise H, Levy D, D'Agostino RB, Sr., Wolf PA, Vasan RS, Benjamin EJ. Obesity and the risk of new-onset atrial fibrillation. JAMA 2004;292:2471-2477.
80. Abed HS, Samuel CS, Lau DH, Kelly DJ, Royce SG, Alasady M, Mahajan R, Kuklik P, Zhang Y, Brooks AG, Nelson AJ, Worthley SG, Abhayaratna WP, Kalman JM, Wittert GA, Sanders P. Obesity results in progressive atrial structural and electrical remodeling: Implications for atrial fibrillation. Heart rhythm : the official journal of the Heart Rhythm Society; 2012.
81. Munger TM, Dong YX, Masaki M, Oh JK, Mankad SV, Borlaug BA, Asirvatham SJ, Shen WK, Lee HC, Bielinski SJ, Hodge DO, Herges RM, Buescher TL, Wu JH, Ma C, Zhang Y, Chen PS, Packer DL, Cha YM. Electrophysiological and hemodynamic characteristics associated with obesity in patients with atrial fibrillation. Journal of the American College of Cardiology 2012;60:851-860.
82. Wong CX, Abed HS, Molaee P, Nelson AJ, Brooks AG, Sharma G, Leong DP, Lau DH, Middeldorp ME, Roberts-Thomson KC, Wittert GA, Abhayaratna WP, Worthley SG, Sanders P. Pericardial fat is associated with atrial fibrillation severity and ablation outcome. J Am Coll Cardiol 2011;57:1745-1751.
83. Al Chekakie MO, Welles CC, Metoyer R, Ibrahim A, Shapira AR, Cytron J, Santucci P, Wilber DJ, Akar JG. Pericardial fat is independently associated with human atrial fibrillation. Journal of the American College of Cardiology 2010;56:784-788.
84. Stevenson IH, Teichtahl H, Cunnington D, Ciavarella S, Gordon I, Kalman JM. Prevalence of sleep disordered breathing in paroxysmal and persistent atrial fibrillation patients with normal left ventricular function. European heart journal 2008;29:1662-1669.
85. Gami AS, Hodge DO, Herges RM, Olson EJ, Nykodym J, Kara T, Somers VK. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol 2007;49:565-571.
86. Gami AS, Pressman G, Caples SM, Kanagala R, Gard JJ, Davison DE, Malouf JF, Ammash NM, Friedman PA, Somers VK. Association of atrial fibrillation and obstructive sleep apnea. Circulation 2004;110:364-367.
87. Otto ME, Belohlavek M, Romero-Corral A, Gami AS, Gilman G, Svatikova A, Amin RS, Lopez-Jimenez F, Khandheria BK, Somers VK. Comparison of cardiac structural and functional changes in obese otherwise healthy adults with versus without obstructive sleep apnea. The American journal of cardiology 2007;99:1298-1302.
88. Lim HE, Kim YH, Kim SH, Kim EJ, Pak HN, Kim YH, Baik I, Shin C. Impact of obstructive sleep apnea on the atrial electromechanical activation time. Circulation journal : official journal of the Japanese Circulation Society 2009;73:249-255.
89. Dimitri H, Ng M, Brooks AG, Kuklik P, Stiles MK, Lau DH, Antic N, Thornton A, Saint DA, McEvoy D, Antic R, Kalman JM, Sanders P. Atrial remodeling in obstructive sleep apnea: Implications for atrial fibrillation. Heart Rhythm 2012;9:321-327.
90. Stevenson IH, Roberts-Thomson KC, Kistler PM, Edwards GA, Spence S, Sanders P, Kalman JM. Atrial electrophysiology is altered by acute hypercapnia but not hypoxemia: Implications for promotion of atrial fibrillation in pulmonary disease and sleep apnea. Heart rhythm : the official journal of the Heart Rhythm Society 2010;7:1263-1270.
91. Linz D, Schotten U, Neuberger HR, Bohm M, Wirth K. Negative tracheal pressure during obstructive respiratory events promotes atrial fibrillation by vagal activation. Heart Rhythm 2011;8:1436-1443.
92. Iwasaki YK, Shi Y, Benito B, Gillis MA, Mizuno K, Tardif JC, Nattel S. Determinants of atrial fibrillation in an animal model of obesity and acute obstructive sleep apnea. Heart Rhythm 2012;9:1409-1416 e1401.
93. Ghias M, Scherlag BJ, Lu Z, Niu G, Moers A, Jackman WM, Lazzara R, Po SS. The role of ganglionated plexi in apnea-related atrial fibrillation. Journal of the American College of Cardiology 2009;54:2075-2083.
94. Linz D, Mahfoud F, Schotten U, Ukena C, Hohl M, Neuberger HR, Wirth K, Bohm M. Renal sympathetic denervation provides ventricular rate control but does not prevent atrial electrical remodeling during atrial fibrillation. Hypertension 2013;61:225-231.
95. Boos CJ, Anderson RA, Lip GY. Is atrial fibrillation an inflammatory disorder? European heart journal 2006;27:136-149.
96. Morgera T, Di Lenarda A, Dreas L, Pinamonti B, Humar F, Bussani R, Silvestri F, Chersevani D, Camerini F. Electrocardiography of myocarditis revisited: Clinical and prognostic significance of electrocardiographic changes. American Heart Journal 1992;124:455-467.
97. Spodick DH. Atrial fibrillation in pericardial disease. Am Heart J 1984;107:809-810.
98. Bruins P, te Velthuis H, Yazdanbakhsh AP, Jansen PG, van Hardevelt FW, de Beaumont EM, Wildevuur CR, Eijsman L, Trouwborst A, Hack CE. Activation of the complement system during and after cardiopulmonary bypass surgery: Postsurgery activation involves c-reactive protein and is associated with postoperative arrhythmia. Circulation 1997;96:3542-3548.
99. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997;96:1180-1184.
100. Stiles MK, John B, Wong CX, Kuklik P, Brooks AG, Lau DH, Dimitri H, Roberts-Thomson KC, Wilson L, De Sciscio P, Young GD, Sanders P. Paroxysmal lone atrial fibrillation is associated with an abnormal atrial substrate: Characterizing the "second factor". J Am Coll Cardiol 2009;53:1182-1191.
101. Wong CX, Stiles MK, John B, Brooks AG, Lau DH, Dimitri H, Kuklik P, Shipp NJ, Sullivan T, Sanders P. Direction-dependent conduction in lone atrial fibrillation. Heart rhythm : the official journal of the Heart Rhythm Society 2010;7:1192-1199.
102. Lau DH, Alasady M, Brooks AG, Sanders P. New-onset atrial fibrillation and acute coronary syndrome. Expert Rev Cardiovasc Ther 2010;8:941-948.
103. Lau DH, Huynh LT, Chew DP, Astley CM, Soman A, Sanders P. Prognostic impact of types of atrial fibrillation in acute coronary syndromes. Am J Cardiol 2009;104:1317-1323.
104. Alasady M, Abhayaratna WP, Leong DP, Lim HS, Abed HS, Brooks AG, Mattchoss S, Roberts-Thomson KC, Worthley MI, Chew DP, Sanders P. Coronary artery disease affecting the atrial branches is an independent determinant of atrial fibrillation after myocardial infarction. Heart rhythm : the official journal of the Heart Rhythm Society 2011;8:955-960.
105. Tjandrawidjaja MC, Fu Y, Kim DH, Burton JR, Lindholm L, Armstrong PW, Investigators CI. Compromised atrial coronary anatomy is associated with atrial arrhythmias and atrioventricular block complicating acute myocardial infarction. Journal of electrocardiology 2005;38:271-278.
106. Sinno H, Derakhchan K, Libersan D, Merhi Y, Leung TK, Nattel S. Atrial ischemia promotes atrial fibrillation in dogs. Circulation 2003;107:1930-1936.
107. Nishida K, Qi XY, Wakili R, Comtois P, Chartier D, Harada M, Iwasaki YK, Romeo P, Maguy A, Dobrev D, Michael G, Talajic M, Nattel S. Mechanisms of atrial tachyarrhythmias associated with coronary artery occlusion in a chronic canine model. Circulation 2011;123:137-146.
108. Alasady M SN, Brooks AG, Lim HS, Lau DH, Barlow D, Kuklik P, Worthley MI, Roberts-Thomson KC, Saint DA, Abhayaratna W, Sanders P. Myocardial infarction and atrial fibrillation: Importance of atrial ischemia. Circ Arrhyhm Electrophysiol In Press.
109. Wolf PA, Dawber TR, Thomas HE, Jr., Kannel WB. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The framingham study. Neurology 1978;28:973-977.
110. Thiedemann KU, Ferrans VJ. Left atrial ultrastructure in mitral valvular disease. The American journal of pathology 1977;89:575-604.
111. Verheule S, Wilson E, Everett Tt, Shanbhag S, Golden C, Olgin J. Alterations in atrial electrophysiology and tissue structure in a canine model of chronic atrial dilatation due to mitral regurgitation. Circulation 2003;107:2615-2622.
112. John B, Stiles MK, Kuklik P, Chandy ST, Young GD, Mackenzie L, Szumowski L, Joseph G, Jose J, Worthley SG, Kalman JM, Sanders P. Electrical remodelling of the left and right atria due to rheumatic mitral stenosis. European heart journal 2008;29:2234-2243.
113. Anne W, Willems R, Roskams T, Sergeant P, Herijgers P, Holemans P, Ector H, Heidbuchel H. Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation. Cardiovascular research 2005;67:655-666.
114. Mayyas F, Niebauer M, Zurick A, Barnard J, Gillinov AM, Chung MK, Van Wagoner DR. Association of left atrial endothelin-1 with atrial rhythm, size, and fibrosis in patients with structural heart disease. Circulation Arrhythmia and electrophysiology 2010;3:369-379.
115. Leone O, Boriani G, Chiappini B, Pacini D, Cenacchi G, Martin Suarez S, Rapezzi C, Bacchi Reggiani ML, Marinelli G. Amyloid deposition as a cause of atrial remodelling in persistent valvular atrial fibrillation. European heart journal 2004;25:1237-1241.
116. Craig RJ, Selzer A. Natural history and prognosis of atrial septal defect. Circulation 1968;37:805-815.
117. Murphy JG, Gersh BJ, McGoon MD, Mair DD, Porter CJ, Ilstrup DM, McGoon DC, Puga FJ, Kirklin JW, Danielson GK. Long-term outcome after surgical repair of isolated atrial septal defect. Follow-up at 27 to 32 years. The New England journal of medicine 1990;323:1645-1650.
118. Morton JB, Sanders P, Vohra JK, Sparks PB, Morgan JG, Spence SJ, Grigg LE, Kalman JM. Effect of chronic right atrial stretch on atrial electrical remodeling in patients with an atrial septal defect. Circulation 2003;107:1775-1782.
119. Roberts-Thomson KC, John B, Worthley SG, Brooks AG, Stiles MK, Lau DH, Kuklik P, Shipp NJ, Kalman JM, Sanders P. Left atrial remodeling in patients with atrial septal defects. Heart rhythm : the official journal of the Heart Rhythm Society 2009;6:1000-1006.
120. Tse HF, Lau CP. Prevalence and clinical implications of atrial fibrillation episodes detected by pacemaker in patients with sick sinus syndrome. Heart 2005;91:362-364.
121. Lau DH, Roberts-Thomson KC, Sanders P. Sinus node revisited. Curr Opin Cardiol 2011;26:55-59.
122. Evans R, Shaw DB. Pathological studies in sinoatrial disorder (sick sinus syndrome). British heart journal 1977;39:778-786.
123. Sanders P, Morton JB, Kistler PM, Spence SJ, Davidson NC, Hussin A, Vohra JK, Sparks PB, Kalman JM. Electrophysiological and electroanatomic characterization of the atria in sinus node disease: Evidence of diffuse atrial remodeling. Circulation 2004;109:1514-1522.
124. De Sisti A, Leclercq JF, Stiubei M, Fiorello P, Halimi F, Attuel P. P wave duration and morphology predict atrial fibrillation recurrence in patients with sinus node dysfunction and atrial-based pacemaker. Pacing Clin Electrophysiol 2002;25:1546-1554.
125. Cosio FG, Aliot E, Botto GL, Heidbuchel H, Geller CJ, Kirchhof P, De Haro JC, Frank R, Villacastin JP, Vijgen J, Crijns H. Delayed rhythm control of atrial fibrillation may be a cause of failure to prevent recurrences: Reasons for change to active antiarrhythmic treatment at the time of the first detected episode. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2008;10:21-27.
126. Tejan-Sie SA, Murray RD, Black IW, Jasper SE, Apperson-Hansen C, Li J, Lieber EA, Grimm RA, Klein AL, Investigators A. Spontaneous conversion of patients with atrial fibrillation scheduled for electrical cardioversion: An acute trial ancillary study. Journal of the American College of Cardiology 2003;42:1638-1643.
127. Schotten U, Duytschaever M, Ausma J, Eijsbouts S, Neuberger HR, Allessie M. Electrical and contractile remodeling during the first days of atrial fibrillation go hand in hand. Circulation 2003;107:1433-1439.
128. John B, Stiles MK, Kuklik P, Brooks AG, Chandy ST, Kalman JM, Sanders P. Reverse remodeling of the atria after treatment of chronic stretch in humans: Implications for the atrial fibrillation substrate. Journal of the American College of Cardiology 2010;55:1217-1226.
129. Sparks PB, Mond HG, Vohra JK, Jayaprakash S, Kalman JM. Electrical remodeling of the atria following loss of atrioventricular synchrony: A long-term study in humans. Circulation 1999;100:1894-1900.
130. Abed HS, Wittert GA, Leong DP, Shirazi MG, Bahrami B, Middeldorp ME, Lorimer MF, Lau DH, Antic NA, Brooks AG, Abhayaratna WP, Kalman JM, Sanders P. Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: A randomized clinical trial. JAMA 2013;310:2050-2060.
131. Ausma J, van der Velden HM, Lenders MH, van Ankeren EP, Jongsma HJ, Ramaekers FC, Borgers M, Allessie MA. Reverse structural and gap-junctional remodeling after prolonged atrial fibrillation in the goat. Circulation 2003;107:2051-2058.
132. Tops LF, Delgado V, Bertini M, Marsan NA, Den Uijl DW, Trines SA, Zeppenfeld K, Holman E, Schalij MJ, Bax JJ. Left atrial strain predicts reverse remodeling after catheter ablation for atrial fibrillation. J Am Coll Cardiol 2011;57:324-331.
133. Yoshida K, Tada H, Ogata K, Sekiguchi Y, Inaba T, Ito Y, Sato Y, Sato A, Seo Y, Kandori A, Aonuma K. Electrogram organization predicts left atrial reverse remodeling after the restoration of sinus rhythm by catheter ablation in patients with persistent atrial fibrillation. Heart Rhythm 2012;9:1769-1778.
134. Oakes RS, Badger TJ, Kholmovski EG, Akoum N, Burgon NS, Fish EN, Blauer JJ, Rao SN, DiBella EV, Segerson NM, Daccarett M, Windfelder J, McGann CJ, Parker D, MacLeod RS, Marrouche NF. Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation 2009;119:1758-1767.
135. Shinagawa K, Shiroshita-Takeshita A, Schram G, Nattel S. Effects of antiarrhythmic drugs on fibrillation in the remodeled atrium: Insights into the mechanism of the superior efficacy of amiodarone. Circulation 2003;107:1440-1446.
136. Ashikaga K, Kobayashi T, Kimura M, Owada S, Sasaki S, Iwasa A, Furukawa K, Motomura S, Okumura K. Effects of amiodarone on electrical and structural remodeling induced in a canine rapid pacing-induced persistent atrial fibrillation model. European journal of pharmacology 2006;536:148-153.
137. Thomas L, Boyd A, Thomas SP, Schiller NB, Ross DL. Atrial structural remodelling and restoration of atrial contraction after linear ablation for atrial fibrillation. European heart journal 2003;24:1942-1951.
138. Reant P, Lafitte S, Jais P, Serri K, Weerasooriya R, Hocini M, Pillois X, Clementy J, Haissaguerre M, Roudaut R. Reverse remodeling of the left cardiac chambers after catheter ablation after 1 year in a series of patients with isolated atrial fibrillation. Circulation 2005;112:2896-2903.
139. Manning WJ, Silverman DI. Atrial anatomy and function postcardioversion: Insights from transthoracic and transesophageal echocardiography. Prog Cardiovasc Dis 1996;39:33-46.
140. Jeevanantham V, Ntim W, Navaneethan SD, Shah S, Johnson AC, Hall B, Shah A, Hundley WG, Daubert JP, Fitzgerald D. Meta-analysis of the effect of radiofrequency catheter ablation on left atrial size, volumes and function in patients with atrial fibrillation. The American journal of cardiology 2010;105:1317-1326.
141. Healey JS, Baranchuk A, Crystal E, Morillo CA, Garfinkle M, Yusuf S, Connolly SJ. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: A meta-analysis. Journal of the American College of Cardiology 2005;45:1832-1839.
142. Tsai CT, Chiang FT, Tseng CD, Hwang JJ, Kuo KT, Wu CK, Yu CC, Wang YC, Lai LP, Lin JL. Increased expression of mineralocorticoid receptor in human atrial fibrillation and a cellular model of atrial fibrillation. Journal of the American College of Cardiology 2010;55:758-770.
143. De-An P, Li L, Zhi-Yun X, Jin-Yu H, Zheng-Ming X, Min W, Qiang Y, Shi-Eng H. Increased expression of mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type 2 in human atria during atrial fibrillation. Clinical cardiology 2010;33:23-29.
144. Shi Y, Li D, Tardif JC, Nattel S. Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure. Cardiovascular research 2002;54:456-461.
145. Li D, Shinagawa K, Pang L, Leung TK, Cardin S, Wang Z, Nattel S. Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure. Circulation 2001;104:2608-2614.
146. Yamashita T, Inoue H, Okumura K, Kodama I, Aizawa Y, Atarashi H, Ohe T, Ohtsu H, Kato T, Kamakura S, Kumagai K, Kurachi Y, Koretsune Y, Saikawa T, Sakurai M, Sato T, Sugi K, Nakaya H, Hirai M, Hirayama A, Fukatani M, Mitamura H, Yamazaki T, Watanabe E, Ogawa S, Investigators JRI. Randomized trial of angiotensin ii-receptor blocker vs. Dihydropiridine calcium channel blocker in the treatment of paroxysmal atrial fibrillation with hypertension (j-rhythm ii study). Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2011;13:473-479.
147. Disertori M, Latini R, Barlera S, Franzosi MG, Staszewsky L, Maggioni AP, Lucci D, Di Pasquale G, Tognoni G. Valsartan for prevention of recurrent atrial fibrillation. The New England journal of medicine 2009;360:1606-1617.
148. Murray KT, Rottman JN, Arbogast PG, Shemanski L, Primm RK, Campbell WB, Solomon AJ, Olgin JE, Wilson MJ, Dimarco JP, Beckman KJ, Dennish G, Naccarelli GV, Ray WA, Investigators A. Inhibition of angiotensin ii signaling and recurrence of atrial fibrillation in affirm. Heart rhythm : the official journal of the Heart Rhythm Society 2004;1:669-675.
149. Savelieva I, Kourliouros A, Camm J. Primary and secondary prevention of atrial fibrillation with statins and polyunsaturated fatty acids: Review of evidence and clinical relevance. Naunyn-Schmiedeberg's archives of pharmacology 2010;381:1-13.
150. Kumagai K, Nakashima H, Saku K. The hmg-coa reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model. Cardiovascular research 2004;62:105-111.
151. Shiroshita-Takeshita A, Schram G, Lavoie J, Nattel S. Effect of simvastatin and antioxidant vitamins on atrial fibrillation promotion by atrial-tachycardia remodeling in dogs. Circulation 2004;110:2313-2319.
152. Shiroshita-Takeshita A, Brundel BJ, Burstein B, Leung TK, Mitamura H, Ogawa S, Nattel S. Effects of simvastatin on the development of the atrial fibrillation substrate in dogs with congestive heart failure. Cardiovascular research 2007;74:75-84.
153. Rahimi K, Emberson J, McGale P, Majoni W, Merhi A, Asselbergs FW, Krane V, Macfarlane PW, Executive P. Effect of statins on atrial fibrillation: Collaborative meta-analysis of published and unpublished evidence from randomised controlled trials. Bmj 2011;342:d1250.
154. Mozaffarian D, Psaty BM, Rimm EB, Lemaitre RN, Burke GL, Lyles MF, Lefkowitz D, Siscovick DS. Fish intake and risk of incident atrial fibrillation. Circulation 2004;110:368-373.
155. Frost L, Vestergaard P. N-3 fatty acids consumed from fish and risk of atrial fibrillation or flutter: The danish diet, cancer, and health study. The American journal of clinical nutrition 2005;81:50-54.
156. Brouwer IA, Heeringa J, Geleijnse JM, Zock PL, Witteman JC. Intake of very long-chain n-3 fatty acids from fish and incidence of atrial fibrillation. The rotterdam study. Am Heart J 2006;151:857-862.
157. Berry JD, Prineas RJ, van Horn L, Passman R, Larson J, Goldberger J, Snetselaar L, Tinker L, Liu K, Lloyd-Jones DM. Dietary fish intake and incident atrial fibrillation (from the women's health initiative). The American journal of cardiology 2010;105:844-848.
158. Macchia A, Grancelli H, Varini S, Nul D, Laffaye N, Mariani J, Ferrante D, Badra R, Figal J, Ramos S, Tognoni G, Doval HC, Investigators G. Omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: Results of the forward (randomized trial to assess efficacy of pufa for the maintenance of sinus rhythm in persistent atrial fibrillation) trial. J Am Coll Cardiol 2013;61:463-468.
159. Kumar S, Sutherland F, Morton JB, Lee G, Morgan J, Wong J, Eccleston DE, Voukelatos J, Garg ML, Sparks PB. Long-term omega-3 polyunsaturated fatty acid supplementation reduces the recurrence of persistent atrial fibrillation after electrical cardioversion. Heart Rhythm 2012;9:483-491.
160. Kowey PR, Reiffel JA, Ellenbogen KA, Naccarelli GV, Pratt CM. Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: A randomized controlled trial. JAMA : the journal of the American Medical Association 2010;304:2363-2372.
161. Farquharson AL, Metcalf RG, Sanders P, Stuklis R, Edwards JR, Gibson RA, Cleland LG, Sullivan TR, James MJ, Young GD. Effect of dietary fish oil on atrial fibrillation after cardiac surgery. Am J Cardiol 2011;108:851-856.
162. Nodari S, Triggiani M, Campia U, Manerba A, Milesi G, Cesana BM, Gheorghiade M, Dei Cas L. N-3 polyunsaturated fatty acids in the prevention of atrial fibrillation recurrences after electrical cardioversion: A prospective, randomized study. Circulation 2011;124:1100-1106.
163. Sakabe M, Shiroshita-Takeshita A, Maguy A, Dumesnil C, Nigam A, Leung TK, Nattel S. Omega-3 polyunsaturated fatty acids prevent atrial fibrillation associated with heart failure but not atrial tachycardia remodeling. Circulation 2007;116:2101-2109.
164. Laurent G, Moe G, Hu X, Holub B, Leong-Poi H, Trogadis J, Connelly K, Courtman D, Strauss BH, Dorian P. Long chain n-3 polyunsaturated fatty acids reduce atrial vulnerability in a novel canine pacing model. Cardiovascular research 2008;77:89-97.
165. Lau DH, Psaltis PJ, Carbone A, Kelly DJ, Mackenzie L, Worthington M, Metcalf RG, Kuklik P, Nelson AJ, Zhang Y, Wong CX, Brooks AG, Saint DA, James MJ, Edwards J, Young GD, Worthley SG, Sanders P. Atrial protective effects n-3 polyunsaturated fatty acids: A long-term study in ovine chronic heart failure. Heart rhythm : the official journal of the Heart Rhythm Society 2011;8:575-582.
166. Ramadeen A, Connelly KA, Leong-Poi H, Hu X, Fujii H, Van Krieken R, Laurent G, Holub BJ, Bazinet RP, Dorian P. N-3 polyunsaturated fatty acid supplementation does not reduce vulnerability to atrial fibrillation in remodeling atria. Heart rhythm : the official journal of the Heart Rhythm Society 2012;9:1115-1122 e1114.
167. Li GR, Sun HY, Zhang XH, Cheng LC, Chiu SW, Tse HF, Lau CP. Omega-polyunsaturated fatty acids inhibit transient outward and ultra-rapid delayed rectifier k+currents and na+current in human atrial myocytes. Cardiovascular research 2009;81:286-293.
168. Sarrazin JF, Comeau G, Daleau P, Kingma J, Plante I, Fournier D, Molin Reduced incidence of vagally induced atrial fibrillation and expression levels connexins by n-3 polyunsaturated fatty acids in dogs. Journal of the American College of Cardiology 2007;50:1505-1512.
169. Kumar S, Sutherland F, Teh AW, Heck PM, Lee G, Garg ML, Sparks PB. Effects of chronic omega-3 polyunsaturated fatty acid supplementation on human pulmonary vein and left atrial electrophysiology in paroxysmal atrial fibrillation. Am J Cardiol 2011;108:531-535.
170. Lee KW, Everett THt, Rahmutula D, Guerra JM, Wilson E, Ding C, Olgin JE. Pirfenidone prevents the development of a vulnerable substrate for atrial fibrillation in a canine model of heart failure. Circulation 2006;114:1703-1712.
171. Nakatani Y, Nishida K, Sakabe M, Kataoka N, Sakamoto T, Yamaguchi Iwamoto J, Mizumaki K, Fujiki A, Inoue H. Tranilast prevents atrial remodeling and development of atrial fibrillation in a canine model of atrial tachycardia and left ventricular dysfunction. Journal of the American College of Cardiology 2013;61:582-588.
172. van der Hooft CS, Heeringa J, van Herpen G, Kors JA, Kingma JH, Stricker BH. Drug-induced atrial fibrillation. Journal of the American College of Cardiology 2004;44:2117-2124.
173. De Caterina R, Ruigomez A, Rodriguez LA. Long-term use of anti-inflammatory drugs and risk of atrial fibrillation. Archives of internal medicine 2010;170:1450-1455.
174. Shiroshita-Takeshita A, Brundel BJ, Lavoie J, Nattel S. Prednisone prevents atrial fibrillation promotion by atrial tachycardia remodeling in dogs. Cardiovascular research 2006;69:865-875.
175. Goldstein RN, Ryu K, Khrestian C, van Wagoner DR, Waldo AL. Prednisone prevents inducible atrial flutter in the canine sterile pericarditis model. Journal cardiovascular electrophysiology 2008;19:74-81.
176. Koyama T, Tada H, Sekiguchi Y, Arimoto T, Yamasaki H, Kuroki K, Machino T, Tajiri K, Zhu XD, Kanemoto-Igarashi M, Sugiyasu A, Kuga K, Nakata Aonuma K. Prevention of atrial fibrillation recurrence with corticosteroids after radiofrequency catheter ablation: A randomized controlled trial. Journal of the American College of Cardiology 2010;56:1463-1472.
177. R. Mahajan, A. Brooks, N. Shipp, J. Finne, J. Manavis, C. Samuel, Simon G. Royce,Pawel Kuklik, M. Alasady, K. Roberts-Thomson, P. Sanders. Af and obesity: Impact of weight reduction on the atrial substrate. Heart rhythm : the official journal of the Heart Rhythm Society 2013.
178. Abed.H WG, Middledorp.M, Shirazi.M, Bobak Bahrami, Darryl Leong, Michelle F Lorimer, Dennis H Lau, Anthony G Brooks, Walter Abhayaratna,Jonathan M Kalman,Prashanthan Sanders. Weight and risk factor modification: Impact on atrial fibrillation. Circulation 2012;126.
179. Wachtell K, Gerdts E, Aurigemma GP, Boman K, Dahlof B, Nieminen MS, Olsen MH, Okin PM, Palmieri V, Rokkedal JE, Devereux RB. In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The life study. Blood Press 2010;19:169-175.
180. Okin PM, Wachtell K, Devereux RB, Harris KE, Jern S, Kjeldsen SE, Julius S, Lindholm LH, Nieminen MS, Edelman JM, Hille DA, Dahlof B. Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension. JAMA : the journal of the American Medical Association 2006;296:1242-1248.
181. Shimano M, Tsuji Y, Inden Y, Kitamura K, Uchikawa T, Harata S, Nattel S, Murohara T. Pioglitazone, a peroxisome proliferator-activated receptor-gamma activator, attenuates atrial fibrosis and atrial fibrillation promotion in rabbits with congestive heart failure. Heart rhythm : the official journal of the Heart Rhythm Society 2008;5:451-459.
182. Korantzopoulos P, Kokkoris S, Kountouris E, Protopsaltis I, Siogas K, Melidonis A. Regression of paroxysmal atrial fibrillation associated with thiazolidinedione therapy. Int J Cardiol 2008;125:e51-53.
183. Oliveira W, Campos O, Cintra F, Matos L, Vieira ML, Rollim B, Fujita L, Tufik S, Poyares D. Impact of continuous positive airway pressure treatment on left atrial volume and function in patients with obstructive sleep apnoea assessed by real-time three-dimensional echocardiography. Heart 2009;95:1872-1878.
184. Patel D, Mohanty P, Di Biase L, Shaheen M, Lewis WR, Quan K, Cummings JE, Wang P, Al-Ahmad A, Venkatraman P, Nashawati E, Lakkireddy D, Schweikert R, Horton R, Sanchez J, Gallinghouse J, Hao S, Beheiry S, Cardinal DS, Zagrodzky J, Canby R, Bailey S, Burkhardt JD, Natale A. Safety and efficacy of pulmonary vein antral isolation in patients with obstructive sleep apnea: The impact of continuous positive airway pressure. Circulation Arrhythmia and electrophysiology 2010;3:445-451.
185. Belhassen B. Cpap after cpvi: The recipe for improving the success rate of ablation in patients with obstructive sleep apnea and atrial fibrillation? Journal of the American College of Cardiology 2013